Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
JAMA|February 21, 2020
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical TrialBruce C V Campbell, Peter J Mitchell, Leonid Churilov, et al.
Annals of Neurology|September 27, 2018
Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhageGeorgios Tsivgoulis, Duncan Wilson, Aristeidis H Katsanos, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
JAMA Neurology|February 22, 2023
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsThomas R Meinel, Duncan Wilson, Henrik Gensicke, et al.
Pageof 4